Genetic Testing for Early-Onset Atrial Fibrillation-Is It Time to Personalize Care?
作者信息
McNally Elizabeth M, Khan Sadiya S
机构信息
Center for Genetic Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Bluhm Cardiovascular Institute, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
出版信息
JAMA Cardiol. 2022 Jul 1;7(7):669-671. doi: 10.1001/jamacardio.2022.0909.
Abstract
摘要
相似文献
1
Genetic Testing for Early-Onset Atrial Fibrillation-Is It Time to Personalize Care?早发性心房颤动的基因检测——是时候实现个性化医疗了吗？
JAMA Cardiol. 2022 Jul 1;7(7):669-671. doi: 10.1001/jamacardio.2022.0909.
2
Genetically based atrial fibrillation: Current considerations for diagnosis and management.基于基因的心房颤动：诊断与管理的当前考量
J Cardiovasc Electrophysiol. 2022 Aug;33(8):1944-1953. doi: 10.1111/jce.15446. Epub 2022 Mar 19.
3
Functional consequences of genetic variation in sodium channel modifiers in early onset lone atrial fibrillation.钠离子通道修饰基因变异对早发性孤立性心房颤动的功能影响。
Per Med. 2018 Mar;15(2):93-102. doi: 10.2217/pme-2017-0076. Epub 2018 Jan 31.
4
New advances in the genetic basis of atrial fibrillation.心房颤动的遗传学基础新进展。
J Cardiovasc Electrophysiol. 2012 Dec;23(12):1400-6. doi: 10.1111/j.1540-8167.2012.02445.x. Epub 2012 Oct 15.
5
Screening of KCNN3 in patients with early-onset lone atrial fibrillation.早期起病的孤立性心房颤动患者中 KCNN3 的筛查。
Europace. 2011 Jul;13(7):963-7. doi: 10.1093/europace/eur007. Epub 2011 Mar 11.
6
Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference.心房颤动的个体化管理：第四届心房颤动能力网络/欧洲心律协会共识会议记录。
Europace. 2013 Nov;15(11):1540-56. doi: 10.1093/europace/eut232. Epub 2013 Aug 27.
7
A novel SCN5A gain-of-function mutation M1875T associated with familial atrial fibrillation.一种与家族性心房颤动相关的新型SCN5A功能获得性突变M1875T。
J Am Coll Cardiol. 2008 Oct 14;52(16):1326-34. doi: 10.1016/j.jacc.2008.07.013.
8
A gain-of-function TBX5 mutation is associated with atypical Holt-Oram syndrome and paroxysmal atrial fibrillation.功能获得性TBX5突变与非典型 Holt-Oram 综合征及阵发性心房颤动相关。
Circ Res. 2008 Jun 6;102(11):1433-42. doi: 10.1161/CIRCRESAHA.107.168294. Epub 2008 May 1.
9
Genome Editing and Atrial Fibrillation.基因组编辑与心房颤动。
Adv Exp Med Biol. 2023;1396:129-137. doi: 10.1007/978-981-19-5642-3_9.
10
Non-genetic risk factors for atrial fibrillation are equally important in both young and old age: A nationwide population-based study.非遗传因素在房颤的发生中同样重要，无论在年轻人还是老年人中：一项全国范围内基于人群的研究。
Eur J Prev Cardiol. 2021 May 22;28(6):666-676. doi: 10.1177/2047487320915664. Epub 2020 Apr 10.
引用本文的文献
1
Atrial Cardiomyopathy in Atrial Fibrillation: Mechanistic Pathways and Emerging Treatment Concepts.心房颤动中的心房心肌病：机制途径与新兴治疗理念
J Clin Med. 2025 May 7;14(9):3250. doi: 10.3390/jcm14093250.
本文引用的文献
1
Mortality Among Patients With Early-Onset Atrial Fibrillation and Rare Variants in Cardiomyopathy and Arrhythmia Genes.早发性心房颤动患者的死亡率与心肌病和心律失常基因中的罕见变异有关。
JAMA Cardiol. 2022 Jul 1;7(7):733-741. doi: 10.1001/jamacardio.2022.0810.
2
Association of Pathogenic DNA Variants Predisposing to Cardiomyopathy With Cardiovascular Disease Outcomes and All-Cause Mortality.致心肌病的致病性 DNA 变异与心血管疾病结局和全因死亡率的相关性研究。
JAMA Cardiol. 2022 Jul 1;7(7):723-732. doi: 10.1001/jamacardio.2022.0901.
3
Correspondence on "ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)" by Miller et al.米勒等人就“美国医学遗传学与基因组学学会（ACMG）关于临床外显子组和基因组测序中次要发现报告的ACMG SF v3.0清单：政策声明”的通信
Genet Med. 2022 Mar;24(3):744-746. doi: 10.1016/j.gim.2021.10.020. Epub 2021 Nov 30.
4
Early-Onset Atrial Fibrillation and the Prevalence of Rare Variants in Cardiomyopathy and Arrhythmia Genes.早发性心房颤动与心肌病和心律失常基因罕见变异的患病率。
JAMA Cardiol. 2021 Dec 1;6(12):1371-1379. doi: 10.1001/jamacardio.2021.3370.
5
Association of Rare Genetic Variants and Early-Onset Atrial Fibrillation in Ethnic Minority Individuals.少数民族个体中罕见遗传变异与早发性心房颤动的关联。
JAMA Cardiol. 2021 Jul 1;6(7):811-819. doi: 10.1001/jamacardio.2021.0994.
6
Genetics of Atrial Fibrillation in 2020: GWAS, Genome Sequencing, Polygenic Risk, and Beyond.2020 年心房颤动的遗传学：GWAS、基因组测序、多基因风险及其他。
Circ Res. 2020 Jun 19;127(1):21-33. doi: 10.1161/CIRCRESAHA.120.316575. Epub 2020 Jun 18.
7
Diversity and inclusion for the All of Us research program: A scoping review.《全民研究计划的多样性和包容性：范围综述》。
PLoS One. 2020 Jul 1;15(7):e0234962. doi: 10.1371/journal.pone.0234962. eCollection 2020.
8
Monogenic and Polygenic Contributions to Atrial Fibrillation Risk: Results From a National Biobank.单基因和多基因对心房颤动风险的贡献：来自国家生物库的结果。
Circ Res. 2020 Jan 17;126(2):200-209. doi: 10.1161/CIRCRESAHA.119.315686. Epub 2019 Nov 6.
9
Genomics-First Evaluation of Heart Disease Associated With Titin-Truncating Variants.基于基因组优先的策略评估与截断性肌联蛋白变异相关的心脏病。
Circulation. 2019 Jul 2;140(1):42-54. doi: 10.1161/CIRCULATIONAHA.119.039573. Epub 2019 Jun 20.
10
Association Between Titin Loss-of-Function Variants and Early-Onset Atrial Fibrillation.肌联蛋白功能丧失变异与早发性心房颤动的关联。
JAMA. 2018 Dec 11;320(22):2354-2364. doi: 10.1001/jama.2018.18179.
Zotero 插件